Form 4 Tracker
Royalty Pharma plc
RPRX

19 insider filings · Latest: May 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 30, 2026Feb 2 9:59 PMMarshall UristEVP, Research & Investments
Sale
20,000$41.09$821.8K0(I)

View →

Jan 23, 2026Jan 26 9:10 PMMarshall UristEVP, Research & Investments
Sale
20,000$40.26$805.1K20,000(I)

View →

Jan 20, 2026Jan 23 9:48 PMTerrance P. CoyneEVP & CFO
Sale
69,582$39.35$2.7M36,010(I)

View →

Jan 16, 2026Jan 20 10:00 PMMarshall UristEVP, Research & Investments
Sale
20,000$39.52$790.3K40,000(I)

View →

Jan 20, 2026Jan 20 9:55 PMTerrance Coyne
Proposed Sale
69,582$39.09$2.7M

View →

Jan 7, 2026Jan 7 10:03 PMGeorge Lloyd
Proposed Sale
495,860$41.39$20.5M

View →

Jan 2, 2026Jan 2 11:22 PMTerrance Coyne
Proposed Sale
69,582$38.86$2.7M

View →

Dec 16, 2025Dec 17 2:41 AMSandy Lamm LLC
Proposed Sale
160,000$38.36$6.1M

View →

Dec 15, 2025Dec 15 11:22 PMTerrance Coyne
Proposed Sale
69,582$38.53$2.7M

View →

Dec 1, 2025Dec 1 10:53 PMTerrance Coyne
Proposed Sale
69,582$39.90$2.8M

View →

Dec 1, 2025Dec 1 10:10 PMUrist Marshall
Proposed Sale
36,484$39.90$1.5M

View →

Dec 1, 2025Dec 1 9:48 PMSandy Lamm LLC
Proposed Sale
46,667$19.93$930.2K

View →

Nov 24, 2025Nov 24 10:24 PMTerrance Coyne
Proposed Sale
69,582$39.75$2.8M

View →

Nov 19, 2025Nov 19 10:41 PMGeorge Lloyd
Proposed Sale
355,426$38.65$13.7M

View →

Nov 17, 2025Nov 17 10:38 PMTerrance Coyne
Proposed Sale
69,594$39.16$2.7M

View →

Aug 11, 2025Aug 11 8:18 PMNorden Gregory
Proposed Sale
33,500$36.23$1.2M

View →

← Previous

Page 2 of 2

Stock Options & Derivatives

No transactions found.